ResearcherWest China Medical Center of Sichuan UniversityActive in the last 2 years
Congya Zhou
Matched on OpenAlex author ID A5110840165. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 11
2015: 1 paper · 2016: none · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper · 2024: 1 paper
Papers 6
- Integrated analysis identifies cuproptosis-related gene DLAT and its competing endogenous RNAs network to predict the prognosis of pancreatic adenocarcinoma pa… Co-author DOI 10.1097/md.0000000000037322↗
- NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer. Co-author DOI 10.1002/cam4.5774↗
- ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma. First author DOI 10.1097/md.0000000000019413↗
- Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis. Co-author DOI 10.3892/ol.2019.10889↗
- High levels of serum glypican-1 indicate poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/cam4.1833↗
- Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer. Co-author DOI 10.18632/oncotarget.4529↗
Closest collaborators
The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Qing Zhu · 5 shared papers, 2015–2023 · strength 0.50
- Paper NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer. DOI 10.1002/cam4.5774↗
- Paper ABO blood type, smoking status, other risk factors and prognosis of pancreatic ductal adenocarcinoma. DOI 10.1097/md.0000000000019413↗
- Paper Evaluation of the target genes of arsenic trioxide in pancreatic cancer by bioinformatics analysis. DOI 10.3892/ol.2019.10889↗
- Zhengchao Gao · 1 shared paper, 2024 · strength 0.31
- Ningna Weng · 2 shared papers, 2019–2020 · strength 0.20
- Qunli Xiong · 1 shared paper, 2023 · strength 0.18
- Yang Yang · 1 shared paper, 2023 · strength 0.18
- Yongfeng Xu · 1 shared paper, 2023 · strength 0.18
- Zhu Zeng · 1 shared paper, 2023 · strength 0.18
- Suxia Han · 2 shared papers, 2015–2019 · strength 0.14
- Shuangshuang Li · 1 shared paper, 2020 · strength 0.11
- Xin Sui · 1 shared paper, 2018 · strength 0.08
- Su‐xia Han · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.